Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer

Overview of attention for article published in Breast cancer targets and therapy, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?

Article in Pharmacological Research (March 2024)

Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate

Article in Pharmaceutics (April 2023)